Online Modules

In their practices, prescribers may encounter patients who are addicted to opioids. Health professionals in general practice may not have sufficient clinical training or experience to properly treat opioid addiction. 

These online modules are designed to increase your understanding of the current state of opioid-dependence treatment, increase your understanding of treatment issues for special populations, and lastly to increase your ability to assess and treat patients.

At the end of each module you will find a link to an online post test, please click the link and complete the post test. Once you have completed the test you will be prompted to begin an online evaluation for the module, when you complete your evaluation you will receive two emails. The first email will detail your score on the post test, the correct answers, an explanation and reference for each question. The second email will contain your Certificate of Completion.

Thank you for your participation in this project. Please email info@pcss-o.org with any questions.

Click the links below to access online modules:

By Elinore F. McCance-Katz, MD, PhD
By Elinore F. McCance-Katz, MD, PhD
By Roger Chou, MD, FACP, Associate Professor of Medicine, Oregon Health & Science University, Director, the Pacific Northwest Evidence-based Practice Center
By William C. Becker, MD, Assistant Professor of Medicine, VA Connecticut Healthcare System, Yale University School of Medicine and David A. Fiellin, MD, Yale University School of Medicine
By Roger Chou, MD, FACP, Associate Professor of Medicine, Oregon Health & Science University, Director, the Pacific Northwest Evidence-based Practice Center
By Stephen A. Wyatt, DO, Department of Psychiatry Middlesex Hospital Middletown, CT
By Jason M. Satterfield, PhD, Professor of Clinical Medicine, University of California, San Francisco
By Jason M. Satterfield, PhD, Professor of Clinical Medicine, University of California, San Francisco
By Charles E. Argoff, MD, Professor of Neurology, Albany Medical College and Director, Comprehensive Pain Center, Albany Medical Center
John A. Renner Jr., MD, CAS Division of Psychiatry Boston University School of Medicinesychiatric Co-Morbidity & Addiction
By Elinore F. McCance-Katz, MD, PhD
By Judith Martin, MD, Medical Director, BAART Turk Street Clinic
By Roger Chou, MD, Associate Professor of Medicine, Oregon Health & Science University, Director, the Pacific Northwest Evidence-based Practice Center
David A. Fiellin, MD, Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine
By Elinore F. McCance-Katz, MD, PhD
By Phyllis A. Grauer, PharmD, CGP, CPE Clinical Pharmacist
By Brian Johnson, MD, Associate Professor Psychiatry and Anesthesia SUNY Upstate Medical University
By Seddon R. Savage, MD, MS, Medical Director, Chronic Pain and Recovery Center, Silver Hill Hospital, New Canaan, CT and Director, Dartmouth Center on Addiction Recovery and Education, Geisel School of Medicine at Dartmouth
By Ward Hagar, MD, Director, Adult Sickle Cell Center Children's Hospital & Research Center Oakland Oakland, California
By Sharon Levy, MD, MPH, Director, Adolescent Substance Abuse Program, Boston Children’s Hospital, Harvard Medical School
By Maria A. Sullivan, MD, PhD, Associate Professor of Clinical Psychiatry, Division on Substance Abuse, Columbia University/New York State Psychiatric Institute
By Binit J. Shah, MD, Ohio Hospital for Psychiatry
By Elinore F. McCance-Katz, MD, PhD
By Jason M. Satterfield, PhD, Professor of Clinical Medicine, University of California, San Francisco
By Binit J. Shah, MD, Senior Instructor, Departments of Anesthesiology & Psychiatry University Hospitals Case Medical Center Cleveland, OH
By Penelope P. Ziegler, MD, Medical Director, Virginia Health Practitioners' Monitoring Program, Associate Professor, Department of Psychiatry, Virginia Commonwealth University
By California Academy of Family Physicians (CAFP)